These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 37636983)

  • 1. Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors.
    Liu WS; Wu LL; Chen CM; Zheng H; Gao J; Lu ZM; Li M
    Mater Today Bio; 2023 Oct; 22():100751. PubMed ID: 37636983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles.
    Wang J; Zhu M; Nie G
    Adv Drug Deliv Rev; 2021 Nov; 178():113974. PubMed ID: 34530015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers.
    Baldassari S; Balboni A; Drava G; Donghia D; Canepa P; Ailuno G; Caviglioli G
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
    Tian X; Shi A; Wu J
    Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Biomedical Materials Derived from Biological Membranes.
    Wang Y; Xu X; Chen X; Li J
    Adv Mater; 2022 Nov; 34(46):e2107406. PubMed ID: 34739155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system.
    Liu H; Su YY; Jiang XC; Gao JQ
    Drug Deliv Transl Res; 2023 Mar; 13(3):716-737. PubMed ID: 36417162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D hybrid structures based on biomimetic membranes and Caryophyllus aromaticus - "green" synthesized nano-silver with improved bioperformances.
    Barbinta-Patrascu ME; Badea N; Bacalum M; Ungureanu C; Suica-Bunghez IR; Iordache SM; Pirvu C; Zgura I; Maraloiu VA
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():120-137. PubMed ID: 31029305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of lipid nanovesicle drug delivery system in cancer immunotherapy.
    Ding Y; Wang L; Li H; Miao F; Zhang Z; Hu C; Yu W; Tang Q; Shao G
    J Nanobiotechnology; 2022 May; 20(1):214. PubMed ID: 35524277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system.
    Jiang XC; Zhang T; Gao JQ
    Adv Drug Deliv Rev; 2022 Aug; 187():114324. PubMed ID: 35640803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New-Generation Platform for Biomedical Applications.
    Naskar A; Cho H; Lee S; Kim KS
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic liposomes hybrid with erythrocyte membrane modulate dendritic cells to ameliorate systemic lupus erythematosus.
    Hao X; Gan J; Cao J; Zhang D; Liang J; Sun L
    Mater Today Bio; 2023 Jun; 20():100625. PubMed ID: 37091811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery.
    Liu Y; Xie X; Chen H; Hou X; He Y; Shen J; Shi J; Feng N
    Nanomedicine; 2020 Oct; 29():102237. PubMed ID: 32534047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.
    Ding J; Ding X; Liao W; Lu Z
    Mater Today Bio; 2024 Feb; 24():100913. PubMed ID: 38188647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of biomimetic nanomaterials made from glioma cell- derived extracellular vesicles in targeted delivery of STAT3-siRNA.
    Hu D; Li X; Nie S; Wang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1646-1654. PubMed ID: 36748374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid membrane-based therapeutics and diagnostics.
    Carvalho PM; Makowski M; Domingues MM; Martins IC; Santos NC
    Arch Biochem Biophys; 2021 Jun; 704():108858. PubMed ID: 33798534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease.
    Yin T; Liu Y; Ji W; Zhuang J; Chen X; Gong B; Chu J; Liang W; Gao J; Yin Y
    Theranostics; 2023; 13(4):1264-1285. PubMed ID: 36923533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.